<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mitropoulos, Panagiotis G</style></author><author><style face="normal" font="default" size="100%">Chatziralli, Irini P</style></author><author><style face="normal" font="default" size="100%">Peponis, Vasileios G</style></author><author><style face="normal" font="default" size="100%">Drakos, Evangelos</style></author><author><style face="normal" font="default" size="100%">Parikakis, Efstratios A</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Intravitreal ranibizumab for the treatment of Irvine-Gass syndrome</style></title><secondary-title><style face="normal" font="default" size="100%">Ocular immunology and inflammation</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year></dates><number><style face="normal" font="default" size="100%">3</style></number><publisher><style face="normal" font="default" size="100%">Informa Healthcare</style></publisher><volume><style face="normal" font="default" size="100%">23</style></volume><pages><style face="normal" font="default" size="100%">225–231</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>